By CentreForMedicalHumanities.org Research Team
How Do Clinical Studies Actually Measure “Quality of Life”?
When a study claims a treatment “improved quality of life” or helped patients “function better day to day,” that claim rests on a specific measurement tool, not a vague impression. Regulators and researchers use a defined family of instruments called clinical outcome assessments to capture how a patient feels, functions, or performs specific tasks — and each type has its own rules for what it can and cannot prove. Understanding these categories helps you read a study's claims with the right amount of confidence.
Terms to Know
- Clinical outcome assessment (COA): Any measurement of how a patient feels, functions, or survives, whether reported by the patient, a clinician, an observer, or captured through a task the patient performs.
- Patient-reported outcome (PRO): A report that comes directly from the patient about their own health status, with no interpretation added by anyone else.
- Clinician-reported outcome (ClinRO): A measurement based on a trained health professional's observation and judgment, such as rating the severity of a visible skin condition.
- Observer-reported outcome (ObsRO): A report from someone who observes the patient in daily life, such as a parent or caregiver, without adding clinical interpretation.
- Performance outcome (PerfO): A measurement based on a standardized task the patient actually performs, such as a timed walking test.
- Health-related quality of life (HRQL): A broad, multi-domain concept covering the effect of illness and treatment on physical, psychological, and social aspects of life.
- Content validity: Evidence that a measurement tool actually captures the concept it claims to measure, built from direct patient input.
- Responder definition: A pre-set threshold of score change that a study treats as a meaningful improvement for an individual patient.
The Four Types of Clinical Outcome Assessment
According to the FDA-NIH Biomarker Working Group's BEST Resource glossary, every clinical outcome assessment falls into one of four categories, and the difference matters because each one answers a different question.
- Patient-reported outcome (PRO): Comes straight from the patient. Examples include a numeric pain-intensity rating or the Minnesota Living with Heart Failure Questionnaire. PRO measures are the only way to capture symptoms that are known only to the patient, such as pain or fatigue.
- Clinician-reported outcome (ClinRO): Comes from a trained professional's judgment. Examples include the Psoriasis Area and Severity Index for skin severity or the Hamilton Depression Rating Scale. ClinRO measures cannot directly capture symptoms only the patient can feel.
- Observer-reported outcome (ObsRO): Comes from a parent, caregiver, or someone who sees the patient in daily life, without adding clinical interpretation. It's especially useful for infants or people who cannot report for themselves, such as a caregiver's log of seizure episodes.
- Performance outcome (PerfO): Comes from a task the patient actually does, under standardized conditions. Examples include a timed 25-foot walk test or a word-recall test for memory.
Our Research Translations section regularly walks through studies that cite one of these measures, since the type of measurement used directly shapes what a study can and cannot claim.
Why “Quality of Life” Alone Isn't a Precise Claim
It may be surprising, but the FDA's own guidance states that “quality of life” as a bare term is too general and undefined to support a specific claim about a medical product, because it implies an evaluation of non-health aspects of life and means different things to different patients. That's why researchers and regulators favor more precise terms:
- A single, well-defined symptom or function (like pain intensity or walking speed) supports a narrow, specific claim.
- Health-related quality of life (HRQL) is an accepted multi-domain concept, but a claim of “improved HRQL” requires that all the important domains were measured, that improvement was shown overall, and that no domain got worse.
- A single-item, “how is your life overall” style question is rarely enough evidence for a broad claim, because it cannot show which specific aspect of daily function actually changed.
When you see a “quality of life” claim in a study summary or headline, the useful question is: which specific instrument, measuring which specific concept, actually produced that result?
A Field Guide: How a Function-Measuring Instrument Gets Built and Vetted
The FDA's guidance on patient-reported outcome measures lays out an iterative development process. Knowing these steps helps you judge whether a measurement tool used in a study you're reading about is a well-established one or a newly invented, unproven one.
- Define the concept. Researchers specify exactly what they intend to measure — a single symptom, or a broader function like physical mobility — and identify who the instrument is meant for.
- Generate items with patient input. Questions or tasks are drafted using literature review, focus groups, and direct patient interviews, so the wording reflects what actually matters to people living with the condition.
- Test patient understanding. Cognitive interviews check whether patients interpret the questions, response choices, and time frame the way the instrument intends.
- Confirm content validity. Researchers document that the items and domains are complete and relevant to the population being studied — not just borrowed from an unrelated group of patients.
- Test reliability and ability to detect change. The instrument must produce consistent scores when a patient's condition hasn't changed, and must be able to register a difference when it has.
- Set a responder definition. Before the trial, researchers pre-specify what amount of score change counts as a meaningful individual improvement, rather than deciding this after seeing the results.
A study that skips these steps — say, by using a homemade questionnaire with no documented patient input or reliability testing — is offering a much weaker form of evidence than one using an instrument that has been through this full process. This is the same kind of evidence-quality check our Evidence Standards apply when reviewing how a study's methodology supports (or doesn't support) the claims made about it.
Questions to Ask When You Read a “Daily Function” Claim
- Which type of outcome measure was used — patient-reported, clinician-rated, observer-reported, or a performance task?
- Was the instrument developed and tested specifically in a population similar to the one you're interested in?
- Was the outcome a primary endpoint the trial was designed and sized to detect, or a secondary or exploratory measure?
- Did the researchers pre-specify what counted as a meaningful improvement, or was that decided after looking at the results?
- Was the trial blinded? Open-label studies, where patients know what treatment they're getting, are rarely considered strong enough on their own to support a functional-improvement claim, because patient expectations can influence self-reported results.
What This Information Does Not Tell You
This article explains how researchers build and evaluate the instruments used to measure daily function and quality of life in clinical studies. It does not evaluate any specific product, treatment, or condition, and it is not a tool for diagnosing a health problem or deciding whether a particular therapy is right for you. The presence of a well-validated outcome measure in a study is one mark of methodological rigor — it is not, by itself, evidence that a specific product or treatment works for a specific person.
Medical Disclaimer
This article is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. CentreForMedicalHumanities.org is an independent publication and is not affiliated with Durham University, the Institute for Medical Humanities, or any academic, clinical, or government institution. Always consult a qualified healthcare provider before making decisions about your health or about participating in a clinical study.
Sources
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, and Center for Devices and Radiological Health. Guidance for Industry: Patient-Reported Outcome Measures — Use in Medical Product Development to Support Labeling Claims. December 2009.
- FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource — Glossary. National Center for Biotechnology Information Bookshelf, National Institutes of Health. Last revised January 2025.
By CMH Evidence Review Editorial Team. Last updated September 2026.